Question 1

Who is Sharon Mates?

Accepted Answer

Sharon Mates serves as Executive at Intra-Cellular Therapies, Inc. (ITCI). They have executed 144 insider transactions totaling $74.9M over their tenure at the company.

Question 2

What is Sharon Mates's role at Intra-Cellular Therapies, Inc.?

Accepted Answer

Sharon Mates holds the position of Executive at Intra-Cellular Therapies, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.

Question 3

Is Sharon Mates buying or selling ITCI stock?

Accepted Answer

Sharon Mates has shown a selling trading pattern, with $0 in total purchases and $74.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.

Question 4

What are Sharon Mates's largest insider transactions?

Accepted Answer

The largest transaction by Sharon Mates was on Jan 18, 2024, when they sold $4.4M worth of ITCI shares. This transaction involved 67,597 shares at $65.19 per share.

Question 5

What is Sharon Mates's trading accuracy?

Accepted Answer

Sharon Mates has a Personal Accuracy Score of 81/100, which measures the historical performance of their insider transactions. This score is calculated based on the timing and performance of their trades relative to market movements.

Question 6

How many companies is Sharon Mates associated with?

Accepted Answer

Sharon Mates has filed Form 4 transactions for 2 different companyies. Their primary association is with Intra-Cellular Therapies, Inc. (ITCI), where they serve as Executive.

Question 7

How much ITCI stock does Sharon Mates own?

Accepted Answer

Sharon Mates currently owns 31,500 shares of Intra-Cellular Therapies, Inc. (ITCI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.

Question 8

What is Sharon Mates's equity in Intra-Cellular Therapies, Inc.?

Accepted Answer

Sharon Mates's equity position in Intra-Cellular Therapies, Inc. consists of 31,500 shares valued at approximately $0. As Executive, they have executed 144 insider transactions, with $0 in purchases and $74.9M in sales.

Question 9

Where can I find Sharon Mates's SEC Form 4 filings?

Accepted Answer

All of Sharon Mates's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sharon Mates has 144 Form 4 filings on record as an insider at Intra-Cellular Therapies, Inc..

Question 10

What is Sharon Mates's net worth from ITCI?

Accepted Answer

Based on their current ITCI stock holdings, Sharon Mates has equity worth approximately $0 in Intra-Cellular Therapies, Inc.. This value is based on 31,500 shares at current market prices and does not represent their total net worth, which may include other assets and investments.

DATE	TICKER	VALUE	TYPE	SHARES	PRICE	10b5-1
Jan 22, 2026	BNTC	$0	Award	31,500	$N/A	Discretionary
Aug 30, 2024	ITCI	$437.9K	Option Exercise	34,396

Sharon Mates

Position Evolution

Equity Curve

Trading Analytics

Recent Transactions

Largest Transactions

Companies Associated

Sharon Mates Trading Summary

How Much ITCI Stock Does Sharon Mates Own?

Is Sharon Mates Buying or Selling ITCI?

Sharon Mates's Recent Stock Transactions

Frequently Asked Questions

Track Sharon Mates's Trades